Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis

NCT04262167 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis and Progressive Fibrotic Interstitial Lung Disease

Interventions

BIOLOGICAL: Lung Spheroid Stem Cells 100 million
BIOLOGICAL: Lung Spheroid Stem Cells 200 million

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]